These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35025763)

  • 1. Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis.
    Sasaki K; Terker AS; Tang J; Cao S; Arroyo JP; Niu A; Wang S; Fan X; Zhang Y; Bennett SR; Zhang MZ; Harris RC
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35025763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective effect of
    Feng W; Ying WZ; Li X; Curtis LM; Sanders PW
    Am J Physiol Renal Physiol; 2021 Jan; 320(1):F87-F96. PubMed ID: 33283645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy.
    Ren J; Rudemiller NP; Wen Y; Lu X; Privratsky JR; Crowley SD
    Kidney Int; 2020 Jan; 97(1):119-129. PubMed ID: 31685313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN Regulatory Factor 4 Controls Post-ischemic Inflammation and Prevents Chronic Kidney Disease.
    Lorenz G; Moschovaki-Filippidou F; Würf V; Metzger P; Steiger S; Batz F; Carbajo-Lozoya J; Koziel J; Schnurr M; Cohen CD; Schmaderer C; Anders HJ; Lindenmeyer M; Lech M
    Front Immunol; 2019; 10():2162. PubMed ID: 31632388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation.
    Sasaki K; Terker AS; Pan Y; Li Z; Cao S; Wang Y; Niu A; Wang S; Fan X; Zhang MZ; Harris RC
    J Am Soc Nephrol; 2021 May; 32(5):1037-1052. PubMed ID: 33619052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice.
    Urate S; Wakui H; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Taguchi S; Tsukamoto S; Kinguchi S; Uneda K; Kanaoka T; Atobe Y; Funakoshi K; Yamashita A; Tamura K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin D Promotes Acute, but Not Chronic, Kidney Injury in a Mouse Model of Aristolochic Acid Toxicity.
    Leong KG; Ozols E; Kanellis J; Ma FY; Nikolic-Paterson DJ
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.
    Liang H; Liu B; Gao Y; Nie J; Feng S; Yu W; Wen S; Su X
    Front Immunol; 2022; 13():978262. PubMed ID: 36159833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages.
    Zhu C; Zheng R; Han X; Tang Z; Li F; Hu X; Lin R; Shen J; Pei Q; Wang R; Wei G; Peng Z; Chen W; Liang Z; Zhou Y
    Cell Death Dis; 2024 Jun; 15(6):397. PubMed ID: 38844455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway.
    Wang X; Xue N; Zhao S; Shi Y; Ding X; Fang Y
    Cell Death Dis; 2020 Aug; 11(8):620. PubMed ID: 32796834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of proximal tubular suppressor of cytokine signaling 3 enhances tubular cell cycling and modifies macrophage phenotype during acute kidney injury.
    Susnik N; Sörensen-Zender I; Rong S; von Vietinghoff S; Lu X; Rubera I; Tauc M; Falk CS; Alexander WS; Melk A; Haller H; Schmitt R
    Kidney Int; 2014 Jun; 85(6):1357-68. PubMed ID: 24402091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization.
    Eguchi J; Kong X; Tenta M; Wang X; Kang S; Rosen ED
    Diabetes; 2013 Oct; 62(10):3394-403. PubMed ID: 23835343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aristolochic acid I determine the phenotype and activation of macrophages in acute and chronic kidney disease.
    Honarpisheh M; Foresto-Neto O; Steiger S; Kraft F; Koehler P; von Rauchhaupt E; Potempa J; Adamowicz K; Koziel J; Lech M
    Sci Rep; 2018 Aug; 8(1):12169. PubMed ID: 30111809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-382 Promotes M2-Like Macrophage
    Wang X; Jia P; Ren T; Zou Z; Xu S; Zhang Y; Shi Y; Bao S; Li Y; Fang Y; Ding X
    Front Immunol; 2022; 13():864984. PubMed ID: 35585990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B
    Navarro Garrido A; Kim YC; Oe Y; Zhang H; Crespo-Masip M; Goodluck HA; Kanoo S; Sanders PW; Bröer S; Vallon V
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F455-F467. PubMed ID: 35979966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice.
    Dai XY; Huang XR; Zhou L; Zhang L; Fu P; Manthey C; Nikolic-Paterson DJ; Lan HY
    Oncotarget; 2016 Mar; 7(10):10841-56. PubMed ID: 26909597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies.
    Lebeau C; Debelle FD; Arlt VM; Pozdzik A; De Prez EG; Phillips DH; Deschodt-Lanckman MM; Vanherweghem JL; Nortier JL
    Nephrol Dial Transplant; 2005 Nov; 20(11):2321-32. PubMed ID: 16077141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.
    Ishii T; Kumagae T; Wakui H; Urate S; Tanaka S; Abe E; Suzuki T; Yamaji T; Kinguchi S; Kobayashi R; Haruhara K; Nakamura T; Kobayashi S; Tamura K
    FEBS Open Bio; 2021 Feb; 11(2):507-518. PubMed ID: 33448693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation.
    Romanov V; Whyard TC; Waltzer WC; Grollman AP; Rosenquist T
    Arch Toxicol; 2015 Jan; 89(1):47-56. PubMed ID: 24792323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of REV-ERBα dysregulation and ferroptosis in aristolochic acid I-induced renal injury.
    Wang Y; Wang Z; Wu Z; Chen M; Dong D; Yu P; Lu D; Wu B
    Biochem Pharmacol; 2021 Nov; 193():114807. PubMed ID: 34673015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.